Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment

NCT01941043 is registered in ClinicalTrials.gov with Avalo Therapeutics, Inc. as lead sponsor.

NCT NCT01941043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01941043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Lead sponsor
Avalo Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
October 31, 2014
Enrollment
1,357 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder